Posts Tagged ‘black box warning’
Pharma Spin Childhood Suicide Rates
Today’s news reports about an increase suicide rate in 2004 offer an opportunity to witness how the media unwittingly disseminates pharmaceutical industry generated propaganda.
Read MorePublic Testimonies at FDA-SSRI-Suicidality Hearings, Dec. 13, 2006
Only if one assumes that the FDA sees the drug industry as its client can some sense be made of December 13th meeting of the FDA’s Psychopharmacologic Drugs Advisory Committee in Silver Springs, Maryland.
Read MoreFormer State Pharmacist (Pennsylvania) Faces Criminal charges
Steven Fiorello, former Chief Pharmacist for the State of Pennsylvania, was arraigned on on Tuesday, November 21, 2006, on Felony and Misdemeanor charges related to his accepting money from drug companies whose drugs he put on the state Formulary.
Read MorePsychiatry operates within a pre-Copernican framework of science
Dr. E. Jane Costello, a professor of psychiatry and behavioral sciences at Duke University, acknowledges: “The system of diagnosis is still 200 to 300 years behind other branches of medicine.” Psychiatry also fails to be guided by an evidence-based positive benefit / risk assessment of its prescribed treatments.
Read MoreCal. NAACP Resolution: End Use of Psyc Drugs on FosterYouth
AHRP applauds the California chapter of the NAACP for unanimously passing a resolution to end the abusive prescribing of psychotropic drugs for children in foster care!
Read MoreInfomail Archive
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability Project Creates "FactSquad" on Rx…
Read More"Depressionology" is Alive and Well
“Depressionology” is Alive and Well Wed, 16 Mar 2005 When science fails to provide a rationale – there is “depressionology” The writer has an article as well as editorial in this APA publication: Andrew A. Nierenberg, Polina Eidelman, Yelena Wu, and Megan Joseph Depression: An Update for the Clinician Contact: Vera Hassner Sharav 212-595-8974 Focus…
Read MoreRisks: Drugs / Vaccines / Trials / Treatments
Risks: Drugs / Vaccines / Trials / Treatment Evidence of antidepressant harm Oct 14, 2005: Andrew Finkelstein Letter to Dr. Russell Katz, Director, Neuropharmacological Drug Products, FDA about FDA’s Failure to Warn about Neurontin-Suicides Aug 29: FDA Response to Utah Court Must Be Truthful Re: Zoloft / SSRI Suicidal Risks Jul 21: Two Court Rulings…
Read MoreAHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising
AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re: Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00. Ellen Liversidge will submit testimony…
Read MoreFDA Official Admits ‘Lapses’ on Vioxx – FDA Didn’t Heed Warnings on Dangers of MS Drug
FDA Official Admits ‘Lapses’ on Vioxx – FDA Didn’t Heed Warnings on Dangers of MS Drug Wed, 2 Mar 2005 As the Senate committee on Health, Education, Labor and Pensions prepares for the second day hearing about FDA’s performance, one hopes that the committee will follow up Tuesday’s hearing with some tough questions about FDA’s…
Read MoreInfomail Archive, 2005
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability Project Creates “FactSquad” on Rx…
Read MoreNIMH Offers Grants to Study SSRI relation to Suicidality – FDA to Examine SSRI- Suicide in Adults
NIMH Offers Grants to Study SSRI relation to Suicidality_FDA to Examine SSRI- Suicide in Adults Mon, 14 Nov 2005 A fifteen year struggle by critics of the drug-centered treatment paradigm in psychiatry is being indirectly validated both by the FDA and the National Institute of Mental Health who are addressing the issue of SSRI and…
Read More